Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Actiphage-supported Clinical Tools for Knowledge-driven Innovations in Diagnostic Solutions for TB in young children

Objective

ACT4KIDS-TB aims at closing the diagnostic gap for paediatric tuberculosis (TB) with a novel pioneering clinical decision-making (CDM)-app incorporating two transformative innovations (three-in-one): Actiphage and computer assisted diagnosis of CXRs (CAD) at the point-of-care (POC).
ACT4KIDS-TB will be the first to determine the diagnostic yield of Actiphage, a repurposed bacteriophage-based PCR assay for blood in children. Actiphage detects viable mycobacteria within hours of sampling & with simplified laboratory requirements versus culture. ACT4KIDS-TB will also externally validate available paediatric CAD algorithms, including smartphone-based CXR images, which will evaluate performance at point-of-care via a new CAD-POC-app. The CDM-app will incorporate results from Actiphage, the CAD POC-app, patient characteristics & features of the setting to provide clinicians with a point-of-care, on-& offline, post-test TB probability to guide treatment decisions.
ACT4KIDS-TB will recruit 206 children with presumptive TB as well as up to 150 health-care-workers and caregivers in South Africa & Benin, two high-TB burden settings. ACT4KIDS-TB includes robust cost-effectiveness, acceptability & feasibility studies for a clear technology transfer roadmap.
ACT4KIDS-TB will add South-South capacity strengthening by providing two Sub-Saharan African PhDs & developing Open Access trainings for paediatric TB diagnosis.
A diverse group of stakeholders facilitates intra-African collaborations; regional manufacturing & support translating research into policy & practice and technology scale-up. These stakeholders comprise industry (e.g. Delft Imaging), policy makers (WHO, Africa CDC, TEI-MAV+, …) as well as global scientific entities (WSPID, WARN-CARN-TB network…)
ACT4KIDS-TB will transform paediatric TB with faster, low-resource, more accessible & cost-effective diagnostics using innovative technologies for a vulnerable population; young children in high-burden settings.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-JU-RIA - HORIZON JU Research and Innovation Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-JU-GH-EDCTP3-2025-04-two-stage

See all projects funded under this call

Coordinator

INSTITUUT VOOR TROPISCHE GENEESKUNDE
Net EU contribution
€ 466 945,00
Address
NATIONALESTRAAT 155
2000 ANTWERPEN
Belgium
Region
Vlaams Gewest Prov. Antwerpen Arr. Antwerpen
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 886 007,00

Participants (5)